Combined application of anti-tumor antibiotic doxorubicin and inhibitor MTOR - rapamicine restores the sensitivity of leukemia cells ТНР-1 infected with human cytomogalovirus and
- Authors: Chernorizh Y.Y.1, Fedorova N.E1, Yurlov K.I1, Ivanov A.V2, Kushch A.A1
-
Affiliations:
- Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
- Engelhardt Institute of Molecular Biology RAS
- Issue: Vol 14, No 3 (2019)
- Pages: 70-71
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122329
- DOI: https://doi.org/10.23868/gc122329
- ID: 122329
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
Ya. Yu Chernorizh
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
Email: Revengeful_w@mail.ru
Moscow, Russia
N. E Fedorova
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
K. I Yurlov
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
A. V Ivanov
Engelhardt Institute of Molecular Biology RASMoscow, Russia
A. A Kushch
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
References
Supplementary files
